Treatment of severe pulmonary hypertension secondary to chronic lung disease: A multicentre study.
V. Prudencio Ribera (Madrid, Spain), A. Aurtenetxe Pérez (Bilbao, Spain), M. Coronel (Corrientes, Argentina), V. Pérez González (Madrid, Spain), F. Mazo Etxaniz (Bilbao, Spain), M. Velázquez Martín (Madrid, Spain), C. Quezada Loaiza (Madrid, Spain), P. Escribano Subías (Madrid, Spain)
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Session: Pulmonary hypertension in lung diseases
Session type: E-poster session
Number: 292
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Prudencio Ribera (Madrid, Spain), A. Aurtenetxe Pérez (Bilbao, Spain), M. Coronel (Corrientes, Argentina), V. Pérez González (Madrid, Spain), F. Mazo Etxaniz (Bilbao, Spain), M. Velázquez Martín (Madrid, Spain), C. Quezada Loaiza (Madrid, Spain), P. Escribano Subías (Madrid, Spain). Treatment of severe pulmonary hypertension secondary to chronic lung disease: A multicentre study.. 292
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: